Turning science into business: Amplifying mRNA by targeting regRNAs
Drug Discovery World
APRIL 17, 2024
CAMP4 is exploiting these regulatory interactions to specifically control the expression of genes tied to disease. Our proprietary RAP Platform identifies the most impactful regRNA for a given gene and programmes anti-sense oligonucleotides (ASOs) to engage the regRNA and amplify mRNA production. Can you give some examples?
Let's personalize your content